Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964366 · ClinicalTrials.gov registry record · Phase 4
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications
A Phase 4 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT00964366 is a Phase 4 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 53 participants.
The verdict
NCT00964366, a Phase 4 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
This is a randomized, half-face study. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide or dapsone gel and the contra lateral side of the face will remain non-treated to serve as a control.
Interventions
- DRUG clindamycin and benzoyl peroxide
- DRUG Dapsone gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2009-07 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964366
The ClinicalTrials.gov registry entry for NCT00964366 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which clindamycin and benzoyl peroxide is the first listed.
NCT00964366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964366 about?
NCT00964366 is a clinical study titled "Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications". This is a randomized, half-face study. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide or dapsone gel and the contra lateral side of the face will remain non-treated to serve as a control.
What is the current status of trial NCT00964366?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2009-07. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00964366?
The interventions under investigation include: clindamycin and benzoyl peroxide (DRUG), Dapsone gel (DRUG).
Who is sponsoring clinical trial NCT00964366?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.